Searched for
BIOCHEM PHARMACEUTICALS
India hits China, Japan and EU with fresh anti-dumping duties on vitamin and rubber chemical importsThe Indian government is placing anti-dumping duties on Vitamin-A Palmitate from China, Japan, Switzerland, and the EU. Duties are also imp...- Sensex rises! These stocks rallied over 15% on BSE in today's tradeIn the Nifty50 index, 41 stocks closed in the green, while 9 stocks ended in the red.
- Stock market update: Nifty Pharma index falls 0.89% in a weak marketThe Nifty Pharma index was trading 0.89 per cent down at 20583.2.
- Stock market update: Nifty Pharma index advances 0.01%The Nifty Pharma index closed 0.01 per cent up at 20768.35.
- Stock market update: Nifty Pharma index falls 0.48% in a weak marketThe Nifty Pharma index was trading 0.48 per cent down at 20665.75.
- MNC pharma body OPPI appoints Anil Matai as new director generalThe Organisation of Pharmaceutical Producers of India (OPPI) has appointed Anil Matai as its director general. Matai has extensive experien...
- Stock market update: Nifty Pharma index falls 1.31%The Nifty Pharma index closed 1.31 per cent down at 11747.1.
- Stock market update: Nifty Pharma index falls 0.34% in a weak marketThe Nifty Pharma index was trading 0.34 per cent down at 11862.25.
- Stock market update: Nifty Pharma index advances 0.33% in an upbeat marketThe Nifty Pharma index was trading 0.33 per cent up at 14182.05.
- India begins anti-dumping probe into Vitamin C imports from ChinaVitamin-C is primarily used by the pharmaceutical’s companies for production of various medicines. The product has uses also in the non- ph...
- Anil Bioplus to pump in Rs 150 crore for Greenfield projectsAnil Bioplus to invest Rs 150 crore to produce enzymes and bio-chemical products at Halol, near Vadodara. The project will go on stream fro...
- Cadila Healthcare PAT seen down 16% at Rs 192crNet sales are expected to have grown 4 per cent to Rs 1,466 crore in the first quarter from Rs 1,173 crore in the year-ago period. Earnings...
- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.
- Zydus Cadila in talks to acquire brands and manufacturing facility of Biochem PharmaceuticalsThe deal is expected to be valued at Rs 300-450 cr and will boost Biochem's revenue growth. In fiscal 2009-10, Biochem reported revenues of...
- Shasun inks JV with US-based Nanoparticle BiochemShasun Pharmaceuticals Ltd has entered into a joint venture with US based Nanoparticle Biochem Inc to explore opportunities in the field of...
- Daiichi buys promoter stake in Ranbaxy at Rs 737 per shareJapanese drugmaker Daiichi Sankyo has bought entire 35 per cent promoters stake in Ranbaxy Laboratories at Rs 737 per share.
- Ranbaxy to pick stake in Jupiter BioThe firm said it would seek the approval for the proposal from its Board of Directors on April 12.
- Ranbaxy to buy 14.9% stake in API maker KrebsRanbaxy Laboratories, the largest pharmaceutical company in the country, is picking up a 14.9% stake in Krebs Biochemicals & Industries.
- Sabre Capital to close PE fund next monthRana Talwar-promoted Sabre Capital will close its private equity fund in the next one month. The fund, called the Sabre Abraaj Private Equi...
- M-Scan pact with BioinnovatBioinnovat Research Services, a drug development research services consultancy firm, has become the marketing partner in India for UK-based...
Load More
